#	Query	Results
S42	S29 AND S41	40
S41	S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40	1,081,306
S40	TX allocat* random*	5,281
S39	(MH "Quantitative Studies")	14,919
S38	(MH "Placebos")	9,827
S37	TX placebo*	39,650
S36	TX random* allocat*	5,281
S35	(MH "Random Assignment")	41,699
S34	TX randomi* control* trial*	110,746
S33	TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl* n1 blind*) or (doubl* n1 mask*) ) or TX ( (tripl* n1 blind*) or (tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or (trebl* n1 mask*) )	857,082
S32	TX clinic* n1 trial*	190,012
S31	PT Clinical trial	79,719
S30	(MH "Clinical Trials+")	203,397
S29	S6 AND S28	104
S28	S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27	30,886
S27	TX piroxicam	209
S26	TX(salicylate* or sulindac or acetylsalicylic)	1,237
S25	TX(sulphonanilide* or flufenamic or nimesulide)	100
S24	TX(cyclooxygenase inhibitor* or cyclooxygenase 2 inhibitor*)	801
S23	TX(ponstan or voltaren)	28
S22	TX(acemetacin or celecoxib or dexibuprofen or dexketoprofen or indometacin or ketoprofen)	1,030
S21	TX(rofecoxib* or valdecoxib*)	520
S20	TX(etoricoxib* or lumiracoxib* or parecoxib*)	316
S19	TX(diclofenac or flurbiprofen or ibuprofen or meclofenamic acid or mefenamic acid or naproxen or aspirin)	14,883
S18	TX (COX 2 or COX‐2 or COX2)	5,065
S17	TX nsaid*	3,651
S16	TX nonsteroidal* or TX non steroidal*	12,754
S15	(MM "Cox‐2 Inhibitors")	1,857
S14	(MM "Piroxicam")	104
S13	(MM "Naproxen")	269
S12	(MM "Ketorolac")	273
S11	(MM "Indomethacin")	450
S10	(MM "Ibuprofen")	798
S9	(MM "Diclofenac")	566
S8	(MM "Aspirin")	4,207
S7	(MM "Antiinflammatory Agents, Non‐Steroidal+")	12,096
S6	S1 OR S2 OR S3 OR S4 OR S5	5,662
S5	TX (pelvic N2 pain)	2,557
S4	TX dyschezia	19
S3	TX dyspareuni*	916
S2	TX Endometriosis	2,764
S1	(MM "Endometriosis")	1,702